Shakespeare Wealth Management, LLC TGTX — TG Therapeutics Inc

Ownership history in Shakespeare Wealth Management, LLC  ·  7 quarters on record

AI Ownership Summary

Shakespeare Wealth Management, LLC reported TG Therapeutics Inc (TGTX) in 7 quarterly 13F filings from 2024 Q4 through 2026 Q2. Peak portfolio weight reached 0.11% in 2026 Q2. The latest visible filing shows TGTX at 0.11% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this TGTX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Shakespeare Wealth Management, LLC's position in TG Therapeutics Inc, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

TGTX was reported at 0.11% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.11% in 2026 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q4 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

TGTX stock page Shakespeare Wealth Management, LLC fund profile Shakespeare Wealth Management, LLC full holdings
How Shakespeare Wealth Management, LLC held TGTX — position size vs. price
% of Fund (quarterly)    TGTX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 ADDED — — — 7,390 +75 +1.0% 0.11% $406K 2026-07-20 $53.96
2026 Q1 UNCHANGED — — — 7,315 — 0% 0.06% $243K 2026-04-30 $33.78
2025 Q4 REDUCED — — — 7,315 -55 -0.7% 0.05% $218K 2026-02-06 $28.86
2025 Q3 REDUCED — — — 7,370 -28 -0.4% 0.06% $266K 2025-11-04 $33.81
2025 Q2 UNCHANGED — — — 7,398 — 0% 0.07% $266K 2025-08-12 $27.12
2025 Q1 UNCHANGED — — — 7,398 — 0% 0.08% $292K 2025-05-15 $33.59
2024 Q4 INITIATED — — — 7,398 — — 0.06% $223K 2025-02-13 $30.73

🏢 Other funds also holding TGTX

As of 2026 Q2 — sorted by position size

CONGRESS ASSET MANAGEMENT CO 3Y 7Y 0.88% TEALWOOD ASSET MANAGEMENT INC 3Y 7Y 0.76% NJ State Employees Deferred Compensation Plan 3Y 7Y 0.37% PSP Research LLC 0.29% IFP Advisors, Inc 3Y 7Y 0.21% 1620 INVESTMENT ADVISORS, INC. 3Y 0.13% Portside Wealth Group, LLC 0.11% Trust Co of the South 0.06% Edge Wealth Management LLC 3Y 7Y 0.05% Abound Wealth Management 0.04%

FAQ About Shakespeare Wealth Management, LLC and TGTX

These are the practical questions this page is built to answer before you even open the full history table.

How long has Shakespeare Wealth Management, LLC reported owning TGTX?

Shakespeare Wealth Management, LLC reported TGTX across 7 quarterly 13F filings, from 2024 Q4 through 2026 Q2.

What was the largest reported TGTX position in Shakespeare Wealth Management, LLC's portfolio?

The largest reported portfolio weight for TGTX was 0.11% in 2026 Q2.

What is the latest reported TGTX position on this page?

The most recent filing on this page is 2026 Q2, when Shakespeare Wealth Management, LLC reported 7,390 shares, equal to 0.11% of portfolio, with an estimated market value of $406K.

What does the chart on this TGTX ownership page compare?

The chart compares Shakespeare Wealth Management, LLC's quarterly TGTX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Shakespeare Wealth Management, LLC time their TGTX position?

Based on 13F filing dates vs. subsequent TGTX price moves, Shakespeare Wealth Management, LLC correctly timed 2 out of 3 reported position changes (67%). The annualised alpha on TGTX relative to SPY over the holding period was +27.7%.

← Back to Shakespeare Wealth Management, LLC Holdings